Page last updated: 2024-10-29

iohexol and Cancer of Pituitary

iohexol has been researched along with Cancer of Pituitary in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koh, TS1
Tan, CK1
Cheong, LH1
Lim, CC1
Greenberg, SB1
Magram, G1

Other Studies

2 other studies available for iohexol and Cancer of Pituitary

ArticleYear
Cerebral perfusion mapping using a robust and efficient method for deconvolution analysis of dynamic contrast-enhanced images.
    NeuroImage, 2006, Aug-15, Volume: 32, Issue:2

    Topics: Adenoma; Aged; Artifacts; Blood Flow Velocity; Blood Volume; Brain; Brain Neoplasms; Contrast Media;

2006
Magnetic resonance cystography with gadopenetate dimeglumine of a cystic craniopharyngioma in a child - a technical note.
    Pediatric radiology, 2000, Volume: 30, Issue:2

    Topics: Child, Preschool; Contrast Media; Craniopharyngioma; Extravasation of Diagnostic and Therapeutic Mat

2000